Main content

    Health Information

    The Bethesda System (TBS)

    The Bethesda System (TBS)

    Topic Overview

    The Bethesda system (TBS) of classifying Pap tests was developed by the United States National Cancer Institute (NCI) to provide more detailed information about Pap test results. When lab specialists examine cervical cells, they use this system to report the lab results to doctors.

    Your doctor receives the report from the lab. The report tells your doctor if the cell sample taken during the exam was good enough to be evaluated. It also lets your doctor know if the cells were normal or abnormal or if there was an infection present.

    If the cells were abnormal, they are put in categories, or typed, based on how severe the problem is:

    • Cells that show minor changes but the cause is unknown may be typed as ASC-US (atypical squamous cells of undetermined significance) or ASC-H (atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion).
    • Cells that show definite minor changes but aren't likely to become cancer may be typed as LSIL (low-grade squamous intraepithelial lesions).
    • Cell changes that are more severe and are more likely to become cancer may be typed as HSIL (high-grade squamous intraepithelial lesions) or AGC (atypical glandular cells ).

    Related Information

    Credits

    By Healthwise Staff
    Sarah Marshall, MD - Family Medicine
    Kirtly Jones, MD - Obstetrics and Gynecology
    Last Revised December 12, 2012

    This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

    1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.